New Flow Chemistry Resource Demonstrates the Popularity of Syrris Flow Reactors
News Oct 15, 2013
This useful resource lists over 50 peer-reviewed publications which have taken advantage of flow chemistry reactor set-ups in industries such as pharmaceutical development, petrochemicals, agrochemicals and fine chemical synthesis, showcasing the ever-¬increasing popularity of Syrris’ flow systems. Ranging from the early days of flow chemistry synthesis through to numerous present-day examples, the publications clearly demonstrate the significant influence of Syrris products in this rapidly developing field.
As the longest established provider of laboratory scale flow chemistry systems, Syrris has a wealth of expertise in research and development of flow chemistry technologies. The newly created publication list demonstrates the versatility of the Company’s flow chemistry reactors, including the award winning Asia system. Together with the existing online application guide, this latest publication provides an invaluable source of information that will capture the interest of chemists worldwide, helping to drive forward the use of state-of-the-art flow chemistry techniques for a wide range of applications.
Cell Recycling System Offers Therapeutic Entry Point for Rare Disease TreatmentNews
Scientists have demonstrated how an investigational drug works against a rare, fatal genetic disease, Niemann-Pick type C1 (NPC1).READ MORE
Cancer Cells Force Normal Cells to Act Like Viruses, Helping Tumors SpreadNews
Researchers reveal how cancer cells force normal cells to act like viruses – allowing tumors to grow, resist treatment, and spread.READ MORE
Edith Heard Unanimously Selected as Next Director General of EMBLNews
At its 53rd meeting yesterday, EMBL Council selected Edith Heard as the organization’s fifth Director General. Heard’s mandate is scheduled to begin 1 January 2019.READ MORE
Comments | 0 ADD COMMENT
EMBL Conference: European Conference of Life Science Funders and Foundations
Apr 19 - Apr 20, 2018
EMBL Course: Target Engagement in Biology and Drug Discovery
Feb 19 - Feb 23, 2018